Raltitrexed
CAS No. | 112887-68-0 | Cat. No. | BCP02874 |
Name | Raltitrexed | ||
Synonyms | TDX;ZD 1694;ZD1694;ZD-1694;Tomudex;D1694; ICID1694; D-1694; ICID-1694; D 1694; ICID 1694;; | ||
Formula | C21H22N4O6S | M. Wt | 458.49 |
Description | Raltitrexed (Tomudex) is an antimetabolite drug used in cancer chemotherapy. Raltitrexed (Tomudex) is chemically similar to folic acid and is in the class of chemotherapy drugs called folate antimetabolites. It works by inhibiting Dihydrofolate reductase, an enzyme used in the synthesis of tetrahydrofolate, thereby preventing the synthesis of thymidylate.In a study, there was an inverse relationship between reduced folate cellular content and raltitrexed IC50; this relationship did not, however, reach statistical significance. The only significant relationship was found between basal cellular folylpolyglutamate synthetase activity and raltitrexed IC50r = -0.56, p = 0.03. Tumor cells with a relatively high folylpolyglutamate synthetase activity were more sensitive to raltitrexed cytotoxic effects and vice versa. | ||
Pathways | Cell Cycle/DNA Damage Apoptosis Pathway | ||
Targets | Thymidylate Synthase DNA/RNA Synthesis Antimetabolite |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.